More reads
- Overlooked inactive ingredients in pills can trigger allergic reactions, study finds. (STAT Plus)
- NASH biotech Genfit sets terms for $132 million IPO. (Renaissance Capital)
- At a big cardiology meeting, glitzy tech will collide with sober science. (STAT)
.png)
No hay comentarios:
Publicar un comentario